基础医学与临床 ›› 2009, Vol. 29 ›› Issue (11): 1198-1202.

• 研究论文 • 上一篇    下一篇

阿托伐他汀减轻博莱霉素诱导大鼠实验性肺纤维化

魏路清 刘斌 李振华 郭文娟   

  1. 武警医学院附属医院
  • 收稿日期:2008-09-03 修回日期:2009-01-12 出版日期:2009-11-20 发布日期:2009-11-20
  • 通讯作者: 魏路清

Atorvastatin alleviates pulmonary fibrosis-induced by bleomycin in rats

Lu-qing WEI, Bin LIU, Zhen-hua LI, Wen-juan GUO   

  1. the Affiliated Hospital, Police Army Medical College
  • Received:2008-09-03 Revised:2009-01-12 Online:2009-11-20 Published:2009-11-20
  • Contact: Lu-qing WEI,

摘要: 目的 评价阿托伐他汀对大鼠实验性肺纤维化的作用。方法 大鼠随机分为对照(C)组,模型2、4和6周(M2、M4、M6)组及阿托伐他汀干预2、4和6周(A2、A4、A6)组,博莱霉素制备肺纤维化模型。评价大体标本、病理、肺系数、肺组织羟脯胺酸含量、动脉血气分析、肺泡炎、肺纤维化程度。结果 M2、M4、A2、A4组肺系数较C组显著增高(P<0.05)。各M、A组肺泡炎积分均较C组显著升高(P<0.05)。A4、A6组肺纤维化程度较同期M组显著减轻(P<0.01)。各M、A组肺组织羟脯胺酸显著高于C组(P<0.05),A4组低于M4组(P<0.05)。各M组PaO2较C组下降,以M2组明显(P<0.01),各A组较M组PaO2均有不同程度的升高(P<0.01或0.05)。结论 阿托伐他汀可减轻大鼠实验性肺纤维化,保护作用可能与疗程有关。

关键词: 博莱霉素, 肺纤维化, 大鼠, 阿托伐他汀

Abstract: Objective To investigate the therapeutic effects of atorvastatin on pulmonary fibrosis of rats induced by Bleomycin(BLM). Methods 42 female Wistar rats were randomly divided into 7 groups: the control group(group C), the model group which was furtherly divided into group 2-week(M2), 4-week(M4), 6-week(M6), and atorvastatin-treatment group which was furtherly divided into group 2-week(A2), 4-week(A4), 6-week(A6). Each had 6 rats. Group M and A were induced to pulmonary fibrosis by the method of BLM endotracheal injection, while the group C was injectted with the saline. On 2nd day, group A were given orally atorvastatin by 10mg/ kg. d. Rats were seperately killed on 2nd, 4th and 6th week. After intratracheal injection of BLM. Alveolitis and pulmonary fibrosis were evaluated by pathology, hydroxypmline concentration and PaO2. Results The lung coefficient of group M2, M4, A2 and A4 was higher significantly than group C. The degree of pulmonary fibrosis in group A4 and A6 was improved compared with group M4, M6. Alveolitis and pulmonary fibrosis in group A were improved compared with those in group M.Hydroxypmline concentration in group A and M were significantly higher than that in group C. while A4 was lower than M4 (P<0.01). There was a increase in PaO2 after exposure to BLM, especially the group M2 (P<0.01). Improvement in PaO2 was observed in groups A, compared with M. Conclusion Atorvastatin had effective treatment on pulmonary fibrosis of rats. The effect was significant on 6th week after treatment, which suggest that the effect maybe correlated positively to the treatment duration.

Key words: Bleomycin, Pulmonary fibrosis, Rat, Atorvastatin